Alveolar soft part sarcoma of the oral and maxillofacial region: clinical analysis in a series of 18 patients

Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Apr;119(4):396-401. doi: 10.1016/j.oooo.2014.12.013. Epub 2014 Dec 24.

Abstract

Objectives: To summarize the clinical features, diagnosis, treatment strategies, and prognosis of alveolar soft part sarcoma (ASPS) of the oral and maxillofacial region.

Study design: We performed a retrospective study in a consecutive series of 18 patients with ASPS of the oral and maxillofacial region between 1995 and 2013. Demographic characteristics, tumor sizes, sites, tumor metastasis, diagnosis, treatments, and overall follow-ups were documented.

Results: The 18 patients were diagnosed pathologically with primary tumor developed on the tongue (10), the cheek (5), the pharynx (1), and the gingiva (2) with an average tumor size of 4 cm. At the latest follow-up, 1 patient with lung metastases survived for 23 months; 1 died 3 months after the confirmation of local recurrence and multiple pulmonary metastases; the rest of the patients were disease free and remained in good health.

Conclusions: ASPS of the oral and maxillofacial region appears to have special clinical characteristics.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Female
  • Head and Neck Neoplasms / diagnosis*
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sarcoma, Alveolar Soft Part / diagnosis*
  • Sarcoma, Alveolar Soft Part / pathology
  • Sarcoma, Alveolar Soft Part / therapy*
  • Soft Tissue Neoplasms / diagnosis*
  • Soft Tissue Neoplasms / pathology
  • Soft Tissue Neoplasms / therapy*
  • Survival Rate
  • Treatment Outcome